JORVEZA
Live / Registered — Registered — Section 71 accepted (as of 07 Mar 2025)
What this means for you
Registered since 13 Feb 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79213908
- Registration number
- 5398764
- Mark type
- Stylized text
- Filed
- 13 Jun 2017
- Published for opposition
- 28 Nov 2017
- Registered
- 13 Feb 2018
- Attorney of record
- Eric S. Furman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract
Owner
- Dr. Falk Pharma GmbH, Freiburg, DE
- Dr. Falk Pharma GmbH, DE
- Dr. Falk Pharma GmbH, DE
Prosecution history
- 11 Jul 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 07 Mar 2025 — REGISTERED-SEC.71 ACCEPTED
- 23 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Jul 2024 — TEAS SECTION 71 RECEIVED
- 23 Feb 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Feb 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 Feb 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 24 Oct 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Oct 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 Jun 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 18 May 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 May 2018 — FINAL DISPOSITION PROCESSED
- 13 May 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB